Evidence map›Paper›PMID 31828140›Full record

ArticleBioMed research international2019

The Potential of

Neng Tine Kartinah, Fadilah Fadilah, Ermita Ilyas Ibrahim, Yuliana Suryati

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BioMed research international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. BiombalanceAntioxidants (Basel, Switzerland) · 2025
    Article
  2. Review
  3. Foods (Basel, Switzerland) · 2022
    Review
  4. Review
  5. Review
  6. Preparative HPLC fraction ofSaudi journal of biological sciences · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Neng Tine KartinahDepartment of Medical Physiology, Faculty of Medicine Universitas Indonesia, Jakarta 10430, Indonesia.
Fadilah FadilahDepartment of Chemistry, Faculty of Medicine Universitas Indonesia, Jakarta 10430, Indonesia.
Ermita Ilyas IbrahimDepartment of Medical Physiology, Faculty of Medicine Universitas Indonesia, Jakarta 10430, Indonesia.
Yuliana SuryatiMaster Program in Biomedical Sciences, Faculty of Medicine Universitas Indonesia, Jakarta 10430, Indonesia.ORCID https://orcid.org/0000-0002-1474-839X
University of Indonesia · ID

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGlucagon-like peptide 1 (GLP-1) hormone is an incretin hormone that is secreted in the ileum and plays a role in the pancreas to increase insulin secretion, stimulate proliferation, and prevent pancreatic

methodThis experimental study used 24 experimental animals of Sprague-Dawley type (aged 8-10 weeks, weight 200-250 g) that were divided into 6 groups, namely, (i) normal (C), (ii) normal-Hib 200 (C-Hib200), (iii) normal-Hib 500 (C-Hib500), (iv) DM (C-DM), (v) DM-Hib200, and (vi) DM-Hib500.

resultsThere was a decrease in GLP-1 levels in the ileum of DM rats (

conclusionThe active ingredient of

Indexed as

AnimalsApoptosisBlood GlucoseDiabetes MellitusDisease Models, AnimalGlucagon-Like Peptide 1Glucagon-Like Peptide-1 ReceptorHibiscusHumansIleumIncretinsInsulin-Secreting CellsMolecular Docking SimulationPancreasPlant ExtractsRatsBlood GlucoseGlp1r protein, ratGlucagon-Like Peptide 1Glucagon-Like Peptide-1 ReceptorIncretinsPlant ExtractsSlc5a1 protein, ratSodium-Glucose Transporter 1

Identifiers

PMID31828140
PMCPMC6885171
OpenAlexW2986308343

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.